Arcadia Biosciences Balance Sheet - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$0.93 $0.08 (7.92%) RKDA stock closing price Jan 20, 2017 (Closing)

The financial analysis of a company like Arcadia Biosciences involves checking the three financial statements of the company in detail, of which the balance sheet is one. As in our Arcadia Biosciences stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. A company releases its balance sheet every quarter along with its quarterly results. Arcadia Biosciences had a long term debt of $25.07M at the end of 2016-Q3. Arcadia Biosciences operating cash flow was $-12.77M while Arcadia Biosciences revenue stood at $1.08M. View Arcadia Biosciences quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Marketable Securities43.41M26.87M20.65M26.27M11.29M-----
Raw Materials------1.06M---
Work In Progress----------
Finished Goods------1.56M---
Notes Receivable----------
Other Current Assets1.18M1.39M1.33M0.69M0.67M0.7M0.25M0.27M--
Arcadia Biosciences Total Current Assets
Property Plant & Equipment---5.24M---5.38M--
Accumulated Depreciation---4.65M---4.65M--
Arcadia Biosciences Net Property Plant & Equipment
Investment & Advances3.47M6.91M14.9M19.74M0.5M0.5M0.5M0.5M--
Other Non-Current Assets1.83M1.87M1.83M1.86M2.13M2.1M2.1M2.14M--
Deferred Charges----------
Deposits & Other Assets0.02M0.09M0.17M0.02M0.1M0.11M3.78M2.81M--
Arcadia Biosciences Total Assets
Notes Payable-5.6M4.56M-------
Accounts Payable2.61M2.57M2.79M2.42M3.97M4.67M3.38M3.19M--
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities1.21M1.5M1.36M1.02M3.28M3.65M4.31M2.46M--
Arcadia Biosciences Total Current Liabilities
Deferred Taxes/Income2.17M2.31M2.49M2.63M2.78M2.93M3.07M3.63M--
Convertible Debt----------
Long-Term Debt25.07M25.02M24.97M24.93M19.46M19.34M8.58M8.86M--
Non-Current Capital Leases----------
Other Long-Term Liabilities3M3M3M3M3M3M3M3M--
Arcadia Biosciences Total Liabilities
Minority Interest----------
Preferred Stock------84.57M82.88M--
Common Stock Net0.04M0.04M0.04M0.04M0.04M0.04M----
Capital Surplus173.31M172.91M172.58M172.22M171.85M171.33M27.89M29.2M--
Retained Earnings-145.84M-141.66M-137.11M-131.92M-128.06M-123.45M-119.77M-113.97M--
Treasury Stock----------
Other Liabilities-0.01M-0.01M-0.03M-0.11M------
Arcadia Biosciences Shareholders Equity
Arcadia Biosciences Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Balance sheet for another ticker

The latest Arcadia Biosciences stock price, and Arcadia Biosciences historical stock prices show the stock price movement over time, and the Arcadia Biosciences PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: An asset is a resource that a corporation like Arcadia Biosciences owns and has monetary significance. RKDA assets decreased from $65.7M in 2016-Q2 to $61.58M in 2016-Q3 . Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities include short term loans and long term loans availed by the company to fund its business operations. RKDA stock had total liabilities of $34.07M for quarter 2016-Q3.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio